Shanghai, January 21, 2022: WuXi STA, a subsidiary of WuXi AppTec, today announced its first parenteral formulation manufacturing line at the Wuxi…
Frankfurt, December 07, 2019: CPhI Worldwide, organised by Informa PLC, announce the winners of the prestigious 2019 CPhI Pharma Awards –…
San Diego & Shanghai, December 17, 2018: WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company…
Shanghai, November 15, 2018: WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of Fruquintinib capsules (Elunate®) for metastatic…
Shanghai, September 09, 2018: WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of Fruquintinib capsules (Elunate®) for metastatic…
Agreement follows the recent opening of WuXi STA’s oligonucleotide R&D labs in China and the USA. Shanghai, May 03, 2018: STA…